跳至主要内容
临床试验/CTRI/2022/07/043836
CTRI/2022/07/043836尚未招募2 期

ROLE OF ROHITAKADI VATI IN YAKRITA VIKARA (NON-ALCOHOLIC FATTY LIVER DISEASE) - RRVYV

Dr Shweta Rawat0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •1.Patients with clinical sign and symptom of Yakrita Vikara (Non-alcoholic fatty liver disease) are Aruchi, Hrillasa, Avipaka, Daurbalya, Udara shoola, Asya-vairasya, Anaha.
  • •2. Fatty Liver Grade-1 and Grade-2 based on USG.
  • •3. Liver function test showing raised Alanine amini transferase more than 1.5 times the normal limits.
  • •4. Prediabetic patients.

排除标准

  • •1.Age group <20 years and >60 years.
  • •2.Chronic Renal Failure, Ischemic heart disease, Congestive cardiac failure, Liver cirrhosis, AIDS.
  • •3.Pregnancy and Lactation.
  • •4.Prolonged medication for various systemic disorders.
  • •Grade-3 Fatty Liver.

研究者

发起方
Dr Shweta Rawat

相似试验